Let the Work Begin – Is the shift towards patient-centered healthcare research actually starting?
By Maggie Jalowsky, Sick Cells and Jennifer Bright, Innovation and Value Initiative Patient Engagement Gains Traction Patient engagement in healthcare research is having a moment. Conferences, public policies, and thought leaders have finally begun to echo what so many of us have said for decades – patients, with all their rich complexities, must be at […]
Moving Beyond Theory: The Need for Active Cultivation of the Value Flower
Despite decades of investment in patient-centered health care, we are all too aware that decisions about access and value are typically made in the context of financial risk management, and often without the input of those who should benefit from care. In addition to a myriad of payment reform strategies, rising interest in cost-effectiveness evaluation […]
Ms. Stacey Courtnay Explores Key Findings from IVI and Arthritis Foundation Research
In a commentary published by the American Journal of Managed Care on December 17, 2021, Ms. Stacy Courtnay highlights how lived experiences like hers can inform healthcare research. In “In Evaluating Rheumatoid Arthritis Treatments, Involving Patients is Key,” she also explores key findings from the joint IVI and Arthritis Foundation research paper released in November […]
Jennifer Bright Shares Views on a Patient-Centered Learning Health System
In a Journal of Accountable Care commentary, IVI Executive Director Jennifer Bright writes that to move toward a truly patient-centered learning health system, data transparency and common-good use must be a greater priority. She describes how IVI is a learning lab within the value and health technology assessment community, grounded in the principles of patient-centricity, […]
Getting Value Right
IVI’s Jennifer Bright and Rick Chapman recently published a commentary in STAT describing the urgency of getting value assessment right. Read the full commentary below. It’s time to get health care value assessment right By Jennifer Bright and Richard H. Chapman, April 15, 2021 Trying to gauge the value of new drugs and devices is […]
Partnering for Patient-Centricity
In a commentary published in the American Journal of Managed Care, IVI’s Jennifer Bright, EveryLife Foundation’s Annie Kennedy, and National Health Council’s Eleanor Perfetto teamed up to describe how their organizations are joining forces to advance patient-centric value assessment measurements. “Patient centricity” — engaging with patients as partners, rather than doing on behalf of the […]
How to Strengthen Value Assessment’s Tool Box
With attention increasingly focused on the Biden Administration’s new interest in a German-style panel to determine fair healthcare pricing, Jennifer Bright says we’re at a crucial time to be absolutely clear about value – and how to measure it with patients’ perspectives fully represented. Read about IVI’s principles for HTA in the US on the […]
Measuring Value: COVID-19 Forces a Reassessment
Authors: Patricia Deverka, Jennifer Bright, Louis Garrison, Samuel Nussbaum We have seen the COVID-19 pandemic decimate people’s lives, health care systems, and the global and US economy, with investments by the US government exceeding $4 trillion dollars and with unemployment approaching 20%. In recent days, numerous articles have speculated on the pricing for Gilead’s new […]
Defining Value Starts with Patients
Authors: Alan Balch and Donna Cryer The vast majority of experts agree that we could, and should, be doing a lot more to include input from patients in value assessment, from conceptualization to data inputs to implementation. The crux of the problem is that in today’s world, we end up with models that assign a […]
IVI and the University of Maryland Pharmacy School’s PAVE Center Partner on Patient-Centered Value Assessment
In an article in The Patient, IVI and the Patient-Driven Values in Healthcare Evaluation (PAVE) Center at the University of Maryland School of Pharmacy describe how they develop methods and models that make patient-centered value assessment both scientifically feasible and relevant to real-world decisions across the range of stakeholders. Read the full article here.